From CCD Partners:
We are delighted to present the 2023/24 edition of our Pre-Clinical Contract Research Organisation (CRO) Watchlist. This edition contains 363 independent businesses across Europe and North America, and highlights and applauds 15 of the most innovative operators in the space.
To create this Watchlist, we screened our proprietary chemicals and life sciences database, prepared profiles, and consulted with our expert panel. We then contacted each of the companies identified to check our data, interview the executive leaders, and gain insight into their strategic ambitions.
"This Watchlist includes 363 independent players in the pre-clinical CRO space, each of which has the potential to disrupt the established market in the next few years. These are the ones to watch."
Managing Partner, CCD Partners
Disruptor Watchlist, Pre-Clinical CROs | NanoImaging Services & CCD partners